279 related articles for article (PubMed ID: 32023293)
1. Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials.
Phommasone K; van Leth F; Peto TJ; Landier J; Nguyen TN; Tripura R; Pongvongsa T; Lwin KM; Kajeechiwa L; Thwin MM; Parker DM; Wiladphaingern J; Nosten S; Proux S; Nguon C; Davoeung C; Rekol H; Adhikari B; Promnarate C; Chotivanich K; Hanboonkunupakarn B; Jittmala P; Cheah PY; Dhorda M; Imwong M; Mukaka M; Peerawaranun P; Pukrittayakamee S; Newton PN; Thwaites GE; Day NPJ; Mayxay M; Hien TT; Nosten FH; Cobelens F; Dondorp AM; White NJ; von Seidlein L
PLoS One; 2020; 15(2):e0228190. PubMed ID: 32023293
[TBL] [Abstract][Full Text] [Related]
2. The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR.
Phommasone K; van Leth F; Imwong M; Henriques G; Pongvongsa T; Adhikari B; Peto TJ; Promnarate C; Dhorda M; Sirithiranont P; Mukaka M; Peerawaranun P; Day NPJ; Cobelens F; Dondorp AM; Newton PN; White NJ; von Seidlein L; Mayxay M
Malar J; 2020 Jan; 19(1):4. PubMed ID: 31900172
[TBL] [Abstract][Full Text] [Related]
3. The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial.
von Seidlein L; Peto TJ; Landier J; Nguyen TN; Tripura R; Phommasone K; Pongvongsa T; Lwin KM; Keereecharoen L; Kajeechiwa L; Thwin MM; Parker DM; Wiladphaingern J; Nosten S; Proux S; Corbel V; Tuong-Vy N; Phuc-Nhi TL; Son DH; Huong-Thu PN; Tuyen NTK; Tien NT; Dong LT; Hue DV; Quang HH; Nguon C; Davoeung C; Rekol H; Adhikari B; Henriques G; Phongmany P; Suangkanarat P; Jeeyapant A; Vihokhern B; van der Pluijm RW; Lubell Y; White LJ; Aguas R; Promnarate C; Sirithiranont P; Malleret B; Rénia L; Onsjö C; Chan XH; Chalk J; Miotto O; Patumrat K; Chotivanich K; Hanboonkunupakarn B; Jittmala P; Kaehler N; Cheah PY; Pell C; Dhorda M; Imwong M; Snounou G; Mukaka M; Peerawaranun P; Lee SJ; Simpson JA; Pukrittayakamee S; Singhasivanon P; Grobusch MP; Cobelens F; Smithuis F; Newton PN; Thwaites GE; Day NPJ; Mayxay M; Hien TT; Nosten FH; Dondorp AM; White NJ
PLoS Med; 2019 Feb; 16(2):e1002745. PubMed ID: 30768615
[TBL] [Abstract][Full Text] [Related]
4. Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial.
McLean ARD; Indrasuta C; Khant ZS; Phyo AK; Maung SM; Heaton J; Aung H; Aung Y; Soe K; Swe MMM; von Seidlein L; Tun NN; Tun KM; Day NPJ; Ashley EA; Hlaing T; Kyaw TT; Dondorp AM; Imwong M; White NJ; Smithuis FM
Lancet Infect Dis; 2021 Nov; 21(11):1579-1589. PubMed ID: 34147154
[TBL] [Abstract][Full Text] [Related]
5. The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin-piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos.
Pongvongsa T; Phommasone K; Adhikari B; Henriques G; Chotivanich K; Hanboonkunupakarn B; Mukaka M; Peerawaranun P; von Seidlein L; Day NPJ; White NJ; Dondorp AM; Imwong M; Newton PN; Singhasivanon P; Mayxay M; Pukrittayakamee S
Malar J; 2018 Nov; 17(1):405. PubMed ID: 30390647
[TBL] [Abstract][Full Text] [Related]
6. A Controlled Trial of Mass Drug Administration to Interrupt Transmission of Multidrug-Resistant Falciparum Malaria in Cambodian Villages.
Tripura R; Peto TJ; Chea N; Chan D; Mukaka M; Sirithiranont P; Dhorda M; Promnarate C; Imwong M; von Seidlein L; Duanguppama J; Patumrat K; Huy R; Grobusch MP; Day NPJ; White NJ; Dondorp AM
Clin Infect Dis; 2018 Aug; 67(6):817-826. PubMed ID: 29522113
[TBL] [Abstract][Full Text] [Related]
7. Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme.
Landier J; Parker DM; Thu AM; Lwin KM; Delmas G; Nosten FH;
Lancet; 2018 May; 391(10133):1916-1926. PubMed ID: 29703425
[TBL] [Abstract][Full Text] [Related]
8. The probability of a sequential Plasmodium vivax infection following asymptomatic Plasmodium falciparum and P. vivax infections in Myanmar, Vietnam, Cambodia, and Laos.
von Seidlein L; Peerawaranun P; Mukaka M; Nosten FH; Nguyen TN; Hien TT; Tripura R; Peto TJ; Pongvongsa T; Phommasone K; Mayxay M; Imwong M; Watson J; Pukrittayakamee S; Day NPJ; Dondorp AM
Malar J; 2019 Dec; 18(1):449. PubMed ID: 31888643
[TBL] [Abstract][Full Text] [Related]
9. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trial.
Lon C; Manning JE; Vanachayangkul P; So M; Sea D; Se Y; Gosi P; Lanteri C; Chaorattanakawee S; Sriwichai S; Chann S; Kuntawunginn W; Buathong N; Nou S; Walsh DS; Tyner SD; Juliano JJ; Lin J; Spring M; Bethell D; Kaewkungwal J; Tang D; Chuor CM; Satharath P; Saunders D
PLoS One; 2014; 9(3):e93138. PubMed ID: 24667662
[TBL] [Abstract][Full Text] [Related]
11. Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.
van der Pluijm RW; Imwong M; Chau NH; Hoa NT; Thuy-Nhien NT; Thanh NV; Jittamala P; Hanboonkunupakarn B; Chutasmit K; Saelow C; Runjarern R; Kaewmok W; Tripura R; Peto TJ; Yok S; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Lek D; Huy R; Dhorda M; Chotivanich K; Ashley EA; Mukaka M; Waithira N; Cheah PY; Maude RJ; Amato R; Pearson RD; Gonçalves S; Jacob CG; Hamilton WL; Fairhurst RM; Tarning J; Winterberg M; Kwiatkowski DP; Pukrittayakamee S; Hien TT; Day NP; Miotto O; White NJ; Dondorp AM
Lancet Infect Dis; 2019 Sep; 19(9):952-961. PubMed ID: 31345710
[TBL] [Abstract][Full Text] [Related]
12. Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.
Chu CS; Phyo AP; Turner C; Win HH; Poe NP; Yotyingaphiram W; Thinraow S; Wilairisak P; Raksapraidee R; Carrara VI; Paw MK; Wiladphaingern J; Proux S; Bancone G; Sriprawat K; Lee SJ; Jeeyapant A; Watson J; Tarning J; Imwong M; Nosten F; White NJ
Clin Infect Dis; 2019 Apr; 68(8):1311-1319. PubMed ID: 30952158
[TBL] [Abstract][Full Text] [Related]
13. Contribution of Asymptomatic Plasmodium Infections to the Transmission of Malaria in Kayin State, Myanmar.
Chaumeau V; Kajeechiwa L; Fustec B; Landier J; Naw Nyo S; Nay Hsel S; Phatharakokordbun P; Kittiphanakun P; Nosten S; Thwin MM; Win Tun S; Wiladphaingern J; Cottrell G; Parker DM; Minh MC; Kwansomboon N; Metaane S; Montazeau C; Kunjanwong K; Sawasdichai S; Andolina C; Ling C; Haohankhunnatham W; Christiensen P; Wanyatip S; Konghahong K; Cerqueira D; Imwong M; Dondorp AM; Chareonviriyaphap T; White NJ; Nosten FH; Corbel V
J Infect Dis; 2019 Apr; 219(9):1499-1509. PubMed ID: 30500927
[TBL] [Abstract][Full Text] [Related]
14. Intracluster correlation coefficients in the Greater Mekong Subregion for sample size calculations of cluster randomized malaria trials.
Peerawaranun P; Landier J; Nosten FH; Nguyen TN; Hien TT; Tripura R; Peto TJ; Phommasone K; Mayxay M; Day NPJ; Dondorp A; White N; von Seidlein L; Mukaka M
Malar J; 2019 Dec; 18(1):428. PubMed ID: 31852499
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010.
Leang R; Barrette A; Bouth DM; Menard D; Abdur R; Duong S; Ringwald P
Antimicrob Agents Chemother; 2013 Feb; 57(2):818-26. PubMed ID: 23208711
[TBL] [Abstract][Full Text] [Related]
16. Low risk of recurrence following artesunate-Sulphadoxine-pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan.
Hamid MMA; Thriemer K; Elobied ME; Mahgoub NS; Boshara SA; Elsafi HMH; Gumaa SA; Hamid T; Abdelbagi H; Basheir HM; Marfurt J; Chen I; Gosling R; Price RN; Ley B
Malar J; 2018 Mar; 17(1):117. PubMed ID: 29548285
[TBL] [Abstract][Full Text] [Related]
17. Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial.
Poespoprodjo JR; Burdam FH; Candrawati F; Ley B; Meagher N; Kenangalem E; Indrawanti R; Trianty L; Thriemer K; Price DJ; Simpson JA; Price RN
Lancet Infect Dis; 2022 Mar; 22(3):367-376. PubMed ID: 34710363
[TBL] [Abstract][Full Text] [Related]
18. Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial.
Thriemer K; Degaga TS; Christian M; Alam MS; Rajasekhar M; Ley B; Hossain MS; Kibria MG; Tego TT; Abate DT; Weston S; Mnjala H; Rumaseb A; Satyagraha AW; Sadhewa A; Panggalo LV; Ekawati LL; Lee G; Anose RT; Kiros FG; Simpson JA; Karahalios A; Woyessa A; Baird JK; Sutanto I; Hailu A; Price RN
Lancet; 2023 Dec; 402(10417):2101-2110. PubMed ID: 37979594
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
[TBL] [Abstract][Full Text] [Related]
20. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
